Metropolitan Life Insurance CO Organogenesis Holdings Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$2.61 - $4.49 $6,083 - $10,466	-2,331 Reduced 58.85%	1,630 $4,000
Q2 2023 Aug 10, 2023	BUY	$1.9 - $4.3 $7,525 - $17,032	3,961 New	3,961 $13,000
Q4 2022 Jun 14, 2023	BUY	$2.48 - $3.43 $10,740 - $14,855	4,331 New	4,331 $11.7 Million
Q3 2022 Jun 14, 2023	BUY	$3.14 - $6.43 $13,599 - $27,848	4,331 New	4,331 $14 Million
Q3 2022 Mar 30, 2023	BUY	$3.14 - $6.43 $5,652 - $11,574	1,800 Added 71.12%	4,331 $14,000
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $5,652 - $11,574	1,800 Added 71.12%	4,331 $14,000
Q2 2022 Jun 20, 2023	BUY	$4.74 - $8.15 $11,996 - $20,627	2,531 New	2,531 $12,000
Q2 2022 Mar 30, 2023	SELL	$4.74 - $8.15 $10,015 - $17,220	-2,113 Reduced 45.5%	2,531 $12,000
Q2 2022 Aug 11, 2022	SELL	$4.74 - $8.15 $10,015 - $17,220	-2,113 Reduced 45.5%	2,531 $12,000
Q1 2022 Jun 20, 2023	BUY	$6.47 - $9.57 $30,046 - $44,443	4,644 New	4,644 $35,000
Q1 2022 Mar 30, 2023	SELL	$6.47 - $9.57 $39,609 - $58,587	-6,122 Reduced 56.86%	4,644 $35,000
Q1 2022 May 12, 2022	SELL	$6.47 - $9.57 $39,609 - $58,587	-6,122 Reduced 56.86%	4,644 $35,000
Q4 2021 Jun 21, 2023	BUY	$9.02 - $13.5 $97,109 - $145,341	10,766 New	10,766 $99,000
Q4 2021 Mar 30, 2023	SELL	$9.02 - $13.5 $4,636 - $6,939	-514 Reduced 4.56%	10,766 $99,000
Q4 2021 Feb 15, 2022	SELL	$9.02 - $13.5 $4,636 - $6,939	-514 Reduced 4.56%	10,766 $99,000
Q3 2021 Jun 21, 2023	BUY	$13.71 - $17.18 $154,648 - $193,790	11,280 New	11,280 $160,000
Q2 2021 Mar 30, 2023	BUY	$14.92 - $23.23 $52,637 - $81,955	3,528 Added 45.51%	11,280 $187,000
Q2 2021 Aug 16, 2021	BUY	$14.92 - $23.23 $168,178 - $261,848	11,272 Added 140900.0%	11,280 $187,000
Q1 2021 Jun 26, 2023	BUY	$7.33 - $21.06 $56,822 - $163,257	7,752 New	7,752 $141 Million
Q1 2021 Mar 30, 2023	BUY	$7.33 - $21.06 $25,075 - $72,046	3,421 Added 78.99%	7,752 $141,000
Q1 2021 May 14, 2021	BUY	$7.33 - $21.06 $58 - $168	8 New	8 $141,000

Others Institutions Holding ORGO

# of Institutions

117

Shares Held

63.2M

Call Options Held

25K

Put Options Held

23.2K

Morgan Stanley New York, NY

12M
Shares

$37.1 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

11.8M
Shares

$36.7 Million
2.88% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$15.8 Million
0.0% of portfolio
Deutsche Bank Ag\ Frankfurt Am Main, 2M

4.84M
Shares

$15 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

3.67M
Shares

$11.4 Million
0.0% of portfolio

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account